|
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial |
|
|
|
Titel: |
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial |
Auteur: |
Benjamin, Reuben Jain, Nitin Maus, Marcela V Boissel, Nicolas Graham, Charlotte Jozwik, Agnieszka Yallop, Deborah Konopleva, Marina Frigault, Matthew J Teshima, Takanori Kato, Koji Boucaud, Floriane Balandraud, Svetlana Gianella-Borradori, Athos Binlich, Florence Marchiq, Ibtissam Dupouy, Sandra Almena-Carrasco, Maria Pannaux, Matthieu Fouliard, Sylvain Brissot, Eolia Mohty, Mohamad |
Verschenen in: |
The Lancet. Haematology |
Paginering: |
Jaargang 9 () nr. 11 pagina's e833-e843 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|